News

LOWVELO funds are enabling Leonardo Ferreira, Ph.D., to pursue his ideas to bring cellular therapy to solid tumors for cancer treatment.

In the world of complex diseases, few conditions are as misunderstood – and as life-altering – as Ehlers- Danlos syndrome (EDS).

Hollings enrolled the first patient in a clinical trial of a new type of drug, a bifunctional antibody, for head and neck squamous cell carcinoma.

Ask researchers what the toughest part of their work is, and many will tell you it isn’t complex experiments – it's translating science into a story.

Doctor with MUSC's Aerospace and Human Performance Neurology Program talks about impact of extended time in space on astronauts' health.

Gene therapy is being used against diseases like sickle cell and hemophilia. Could it be used against cancer?

The cochlear implant team at MUSC Health adds a new clinical trial that’s testing a device that may reduce hearing loss that can happen as an implant goes in.

MUSC Health becomes first on East Coast to put under-the-skin cochlear implant in patient in national clinical trial of innovative device.

Researchers, patient advocates, health care professionals and community leaders gather to highlight latest advancements in rare disease research.

After years of decreases, cervical cancer is increasing among women who live in rural areas, research at Hollings Cancer Center shows.

Hollings researchers want to help older adults with head and neck cancer navigate treatment options that have mostly been studied among middle-aged adults.

MUSC Hollings Cancer Center researchers will test whether e-cigarettes are a viable quit smoking option for people who decline other options.

“There's an incredible amount of excitement about this device.” MUSC prepares to place totally under-the-skin cochlear implants in patients with hearing loss.

A researcher from the MUSC has contributed to a study linking childhood exposure to leaded gasoline with a nationwide decline in mental health.

Hollings researcher receives Department of Defense Early Career Scholar Award to improve immune therapies by targeting resistant kidney tumors.

MUSC Hollings Cancer Center researchers found that loosening up a CAR's grip on its Treg improved its function.

MUSC Hollings Cancer Center researcher Dr. Natalie Saini was awarded a Research Scholar Grant by the American Cancer Society.

Dr. Timothy Stemmler will help guide MUSC's mission as a biomedical research institution.

MUSC researchers discover that an important genetic structure influences how the brain interprets emotional experiences to bring about behavioral changes.

Neuropsychologist at MUSC is a senior author with a team that linked importance of new brain cells with verbal memory and intellectual functioning.

As doctors in emergency department see more signs patients have been vaping, they focus on what might help kids kick habit.

On World Pancreatic Cancer Day, researchers and survivors gathered to share progress in the fight against pancreatic cancer.

Precision Health Research Symposium at MUSC highlights experts’ insights about changes that will transform preventive health care and improve health equity.

Cervical cancer deaths in women under 25, who were tweens when the HPV vaccine was introduced, have plunged, Hollings researchers show.

New research shows how Tregs could transform care for type 1 diabetes and eventually cancer and autoimmune diseases.

Blue Sky Labs, incubation space for start-ups and early-stage companies focusing on life sciences and medical research, opens at MUSC.

New research at Hollings shows how the Golgi body, an organelle within cells, could be a biomarker for T-cell tumor-fighting activity.

MUSC Parkinson's Foundation Center of Excellence along with multiple sponsors hosted the highly anticipated Passion for Parkinson’s event.

Trauma and intimate partner violence continue to be neglected as contributors to opioid use disorder. A new digital toolkit aims to change that.

The American Cancer Society awarded Hollings researcher David Long, Ph.D., a Catalyst grant to study how two proteins' interaction affects genomic instability.

Anti-malarial drug shows promise against cancer, but resistance often develops. A Hollings team found out how, setting stage for combination therapies.

Not enough people are aware of lung cancer screening, even though the test can find early-stage, treatable cancer, Hollings researchers find.

Quitting smoking soon after a cancer diagnosis adds an average of two years to a patient's life, a new study finds.

An international collaboration has advanced therapies for co-occurring substance use disorders and PTSD and helped to inform prevention efforts globally.

A new study from MUSC Hollings Cancer Center shows how a receptor called PPAR δ helps disable the immune system so that T-cells can’t kill cancer cells.

MUSC hosts a New Faculty Research Orientation, providing faculty with essential resources and insights to excel.

Models help scientists understand how cancer develops - but researchers haven't had one for most ovarian cancers.

Electronic health record-based screening for intimate partner violence prioritizes confidentiality.

MUSC leaders and the community celebrate faculty achievements in annual recognition event.

Using a novel model for a common fatty liver disease, an MUSC team has identified a pathway that could be targeted to reduce fat accumulation in the liver.

MUSC Hollings researchers find that targeting an immunosuppressive protein on two fronts can reduce metastasis and restore sensitivity to immunotherapy.

MUSC scientists report successful Alaskan expedition for novel therapeutics for pancreatic cancer.

A newly approved targeted therapy for small cell lung cancer is at the forefront of a new type of drug for solid tumors.

Hollings was part of an international clinical trial that led to the FDA approval of a new drug to treat certain types of gliomas.

Two Hollings researchers are working together to develop a new way to get depression treatment to people with likely incurable cancer.

A new study aims to get a better understanding of what dual use of vapes and cigarettes looks like in real world usage.

MUSC scientists identify how cocaine triggers a specific protein in the brain to hijack normal brain circuitry and promote further drug taking.

The Group 3 subtype of medulloblastoma has the worst prognosis of all the subtypes, but new research is pointing to a potential therapy.

The MUSC Hollings Cancer Center white coat ceremony inspires HBCU students to pursue research careers.

A new compound developed by researchers at MUSC Hollings Cancer Center shows promise in overcoming chemotherapy resistance in triple-negative breast cancer.

Howard Hughes Medical Institute chooses MUSC student, adviser for Gilliam Fellows program based on research, commitment to equity and inclusion.

The CREW program encourages early-career women in science to become entrepreneurs.

Too many lung cancer patients don't get all the biomarker testing they should have before beginning treatment. Dr. Adam Fox wants to change that.

A Hollings immunologist will use an American Cancer Society Research Scholar Grant to study ways to make colorectal cancer more susceptible to immunotherapy.

Exhibit showcasing history, mission and achievements of The Duke Endowment, private foundation that funds important work at MUSC and elsewhere, comes to campus.

An MUSC Hollings Cancer Center team describes how the bacteria Porphyromonas gingivalis connects to chemotherapy resistance.

MUSC scientists who study cannabis answer questions about delta-8 THC, a psychoactive substance that’s growing in popularity.

Polyploid giant cancer cells, which are monstrously oversized and contain multiple nuclei, could be culprits in disease recurrence after cancer therapy.

A new study from Hollings researchers suggests a dual approach for targeting pancreatic cancer.

External evaluation of MUSC’s telestroke program confirms that stroke center certification and stroke coordinators improve stroke-care metrics.

A new dedicated phase I clinical trials unit at Hollings means more and different types of clinical trials will be available to cancer patients.

A new study is the first in the U.S. to show that an available generic drug could help people stop using e-cigarettes.

MUSC’s pipeline programs build the skills of underrepresented students and prepare them for careers in health care and medical research.

Leukogene Therapeutics Inc. introduces a promising therapy to treat multiple cancers and hopes to become flagship entity for MUSC’s innovation ecosystem.

A recent MUSC study found that hypertensive disorders of pregnancy may contribute to higher rates of blood clots in women years after delivery.

For people with HIV, the risk of anal cancer varies significantly depending on the region of the country where they live.

MUSC’s ReJoyce Green, Ph.D., leads study highlighted in prestigious publication showing which factors may predict substance use in adolescents.

Renovation for innovation: Blue Sky building on Calhoun to house lab and collaboration space and serve as launch of innovation district.

After melanoma surgery, hairdresser Carol Helton is spreading the word at her hair salon about staying on top of suspicious moles.

Innovation Awareness Month showcases importance of culture at MUSC.

A clinical trial of CAR-T cell therapy developed at Hollings has received NCI funding to expand.

An Ewing sarcoma researcher at MUSC is one of three scientists nationwide to receive a career development award from the Rally Foundation.

Teams working to improve substance use screening in trauma centers and relieve symptoms of a connective tissue disease take home this year’s Blue Sky Awards.

The Department of Psychiatry and Behavioral Sciences ranked ninth in the country for NIH funding in 2023.

Hollings researchers use patented technology to improve immunotherapy by prolonging survival of cancer-fighting T-cells.

Head and neck cancer surgeons at Hollings are testing a fluorescent dye that illuminates nerves, which should make them easier to find during surgery.

Through years of heartache and hard work, widower raises funds for research into the cancer that took his wife.

Working with people with brain tumors brings great satisfaction to South Carolina's only neuro-oncologists.

Two MUSC researchers think that community libraries could hold the potential to improve head and neck cancer awareness.

The South Carolina Rare Disease Council hosted a symposium that gathered rare disease researchers and advocates to chart the path forward for improved care.

South Carolinians interested in cancer survivorship - as providers, researchers, caregivers or survivors - are invited to the first SCOR symposium in June.

MUSC researchers find differences in young adults’ experience of cannabis and risk for cannabis use disorder based on genetics and sex.

Meningioma doesn't attract as much research as other types of brain tumors. But Dr. Ben Strickland believes his patients deserve more options.

The annual PurpleStride walk raises money for pancreatic cancer research at Hollings Cancer Center.

Patrick Flume, M.D., was recently honored with the Cystic Fibrosis Foundation's 2024 Impact Award.

A tobacco researcher at MUSC Hollings Cancer Center was honored by the American Society of Preventive Oncology for his work.

“It’s a really good study, very timely,” says MUSC researcher of trial using weight loss drug to try to improve health of people with HIV.

A new worldwide study finds the blood thinner apixaban to be successful in reducing stroke in patients with subclinical atrial fibrillation.

MUSC researchers discover cellular process that naturally protects the brain after injury, informing future treatments for brain disease.

Physician-researcher Marc Chimowitz was recognized for his lifelong contributions to research mentorship by the American Stroke Association in February.

MUSC neuroscientist Bashar Badran was recently recognized for his trailblazing research by the Helping to End Addiction Long-Term Initiative.

The 6th annual LOWVELO, a bike ride that raises money for lifesaving cancer research at MUSC Hollings Cancer Center, opens for registration on Friday, March 1.

An MUSC Hollings Cancer Center fellow was awarded a national grant to pursue her idea: making short helpful videos for cancer patients trying to stop smoking.

Neuropsychiatric symptoms predict which patients with mild cognitive impairment develop Alzheimer’s disease.

MUSC Health-Florence is one of four sites in the Southeast chosen for the Equitable Breakthroughs in Medicine Development Initiative.

Dr. Charles P. Darby Jr. was an exceptional visionary, leader and advocate for pediatric care in South Carolina.

In a preclinical model, MUSC researchers restore an opioid-weakened brain pathway that controls behavior, thereby preventing relapse.

The parents of millions of teens don't intend to vaccinate them against HPV, a virus that can cause six types of cancer.

Researchers find stagnant HPV vaccine rates among young adults, though LGBTQ vaccination rates are a bright spot.

Dr. Steve Kautz has been awarded $7.9 million NIH grant to build the Clinical Research Center for Restoration of Neural-based Function in the Real World.

Can their older son’s rare, debilitating disorder be treated? British family turns to MUSC scientist whose expertise in MEF2C looks promising.

Breast cancer often develops resistance to previously effective drugs. Hollings researchers showed how the effectiveness of one drug might be restored.

CAR-T-cell therapy can be a powerful treatment for blood cancers, but it also has significant side effects. A clinical trial at Hollings seeks to change that.

MUSC will be one of four sites exploring the genetic basis of Parkinson’s disease in the Black community.

Symposium will bring together researchers and patient advocates to inform policy and chart the way forward for patients with rare diseases.

A decades-long downward trend in cervical cancer incidence and death rates has reversed for women in low-income areas, leading to widening health disparities.

Liver biopsy is crucial to diagnosis in one third of cases.

Alex's Lemonade Stand awarded Dr. Jezabel Rodriguez Blanco a grant to research ways to prevent medulloblastoma relapse, a cancerous brain tumor in kids.

Novel drug shows promise for helping people with a type of heart failure that once left them facing dire prognoses and declining quality of life.

MUSC pilot study shows that an FDA-approved drug called NAC could be useful for reducing the need for opioids after spinal surgery.

MUSC researchers have developed a training curriculum for community health workers to improve cancer genetic screening among Black women.

Carol Feghali-Bostwick, internationally recognized translational researcher, has been named a fellow of the National Academy of Inventors.

MUSC Hollings Cancer Center researchers show anti-cancer effects of Boswellia, from same tree that produces frankincense, in small study.

MUSC Hollings Cancer Center's Dr. Hamza Hashmi helped to write guidelines for hospitals considering offering CAR-T-cell therapy on an outpatient basis.

Dr. William Hawkins is taking on the new role of deputy director of MUSC Hollings Cancer Center to strengthen the focus on translational research.

MUSC employees have new ways to recognize colleagues’ contributions and earn awards through Celebrate! program.

A newly approved drug to prevent neuroblastoma relapse is a huge win for patients and their families, says Jacqueline Kraveka, D.O.

An MUSC Hollings Cancer Center radiation oncologist is testing combining organ-sparing techniques with stereotactic ablative body radiotherapy (SABR).

A 21-day trip to Antarctica has been life-changing for one MUSC Hollings Cancer Center researcher.

MUSC President David Cole names winners of 2023 Values in Action Awards.

MUSC is 1 of 9 leading research universities across 6 states chosen to be part of the Innosphere Ventures Regional Life Sciences Incubator.

MUSC-Clemson team finds that teleconsent is the preferred means of giving clinical trial consent remotely.

A clinical trial of a new drug combination gave hope to a young woman diagnosed with tongue cancer.

Graduate student Sarah Dooley shows young women that brilliant is beautiful by becoming a princess in the lab.

As FDA approves new treatments for sickle cell, patient prepares for trial testing another one. “This has been something that I've been hoping for.”

MUSC brings together experts to talk about precision health, including how it’s being used & what future may hold.

As MUSC works with Clemson and USC on new Alzheimer’s Disease Research Center, scientist sees issue through professional and personal lenses.

MUSC research leader moderates congressional briefing on “invisible threat” of PTSD.

Cervical cancer rates are increasing in Puerto Rico, and researchers from Hollings and the island are working together to increase screening rates.

Most people with an inherited mutation that increases cancer risk have no idea – which is why genetic testing is so important, says Dr. Kevin Hughes.

Researchers at MUSC and Cincinnati Children’s develop a novel colon organoid model with naturally occurring immune cells.

Vaccinating pregnant moms against COVID-19 protects their newborns against severe disease and hospitalization, shows new study with MUSC ties.

Caregiving for family members with cancer can take an emotional and physical toll. Yet few caregivers are screened for distress or connected to resources.

An MUSC Hollings Cancer Center researcher shows that SFRP2 is especially abundant in pancreatic cancer.

New research shows that, for the first time, there are more young people who begin to use nicotine through vaping rather than through cigarettes.

Men of color, who are less likely to use preventive health services, would be more receptive to health messaging from other men of color, pilot study shows.

A drug that Hollings researchers were developing for cancer turns out to restore motor function in aging mice showing signs of neurodegeneration.

When the call came from the Department of Justice’s Office for Victims of Crime, Alyssa Rheingold, Ph.D., and Michael de Arellano, Ph.D., were ready.

MUSC Hollings Cancer Center researchers believe that some already-approved drugs could be used in certain cases where breast cancer has become resistant.

MUSC researchers partner with Emergency Medical Services to pilot test the first MRI-equipped ambulance to speed stroke response.

Thai Ho, M.D., Ph.D., will lead precision oncology efforts at MUSC Hollings Cancer Center.

An increase in cervical cancer deaths in Appalachian Kentucky could point to hidden issues in other regions of persistent poverty.

The MUSC Office of Innovation is proud to announce Fabio Rizzante, D.D.S., Ph.D., as this quarter’s recipient of the I am an MUSC Innovator Award.

A clinical trial at MUSC Hollings Cancer Center is testing a shorter course of radiation therapy for sarcoma patients to ease the logistics of getting care.

Could preparing for and dealing with contagious illnesses such as COVID become as streamlined as getting ready for a storm?

Surveys at 12 cancer centers across the U.S. looked at cannabis usage among cancer patients.

Nanowired cardiac organoids could one day repair hearts instead of just preventing further damage.

LIFT scholars take flight in a new training course for researchers applying for their first NIH R01 grant.

As people with HIV live longer, they are more likely to get cancers that come with age but HIV might complicate treatment.

Local doctors combine community cancer care with access to research through Hollings NCORP-MU.

Scientists at MUSC Hollings Cancer Center think it's possible that CAR-T-cell therapy could be performed without lymphodepleting chemotherapy beforehand.

Three Hollings members – an M.D., a D.D.S. and a Ph.D. – are pooling their expertise to develop a personalized vaccine to prevent oral cancer from returning.

Colbert Lectureship and Faculty Awards and Recognition gathers best of MUSC’s leaders, researchers, educators and clinicians to recognize hard-working efforts.

MUSC Hollings Cancer Center awarded a number of pilot grants through the spring and summer to kickstart research projects on a range of topics.

The Clinical Trialist Training Program offers early-career clinicians the time and know-how to lead clinical trials.

MUSC team shows people with diverse childhood traumas are more likely to use cocaine and opioids. Trauma-focused interventions could help.

The role of e-cigarettes is hotly debated. A new study shows they could have a role in helping adult smokers to quit.

Hollings works with more than a dozen sites in South Carolina to bring clinical trials to the community, including the Ralph H. Johnson VA Health Care System.

MUSC Hollings Cancer Center is leading a national trial to test an intervention to get more head-and-neck cancer patients to radiation therapy on time.

Dr. Benjamin Toll, director of the Tobacco Treatment Program, has been dismayed that so many misunderstand the continuum of risk for tobacco products.

“It's just a really exciting time to be working in this area,” says researcher of trial finding weight loss drug cut risk of serious heart problems.

MUSC studies effects of popular diabetes and weight loss drugs on surgical patients.

Hollings researcher Sophie Paczesny led a multicenter team to identify risk biomarkers of chronic graft-versus-host disease.

Hollings director Dr. Raymond N. DuBois has been honored as a fellow of the Royal College of Physicians.

An accelerated course of transcranial magnetic stimulation could redefine how we treat patients at high risk for developing dementia.

As people across country endure sizzling summer, MUSC experts help lead charge to find better ways to prevent heat-related health problems.

Dr. Teresa Kelechi is inducted into the International Nurse Researcher Hall of Fame in recognition of the broad impact her research has had on patient care.

Bare minimum reimbursement rates could be a factor in why some clinics may be struggling to offer HPV vaccination in the U.S.

Students from four Charleston County high schools spent their summer learning how to research in labs at MUSC Hollings Cancer Center.

Gov. Henry McMaster recognizes work of MUSC researchers James S. Krause, Ph.D., and Lindsay Squeglia, Ph.D.,

Prostate cancer survivor shares his story to encourage other men to know their options and take action.

A new summer intern program empowers young researchers by getting them in the lab to actually help fight their own disease.

The resurgence of research into psychedelic-based treatments is poised to benefit many people who face mental health challenges, but how do they feel about it?

A team of researchers uncovered the structure of a 'hidden pocket' on a KRAS mutation that could enable developing next-generation inhibitors.

MUSC Hollings Cancer Center researchers find that autologous stem cell transplant for multiple myeloma is usually safe as outpatient procedure.

If a first try at quitting smoking doesn't work, should the same method be tried again? Or a new method? Hollings researchers are seeking answers.

"It's been an experience," is Susan Shelton's understated way of explaining her journey with oral cancer.

A Hollings researcher's startup got a Small Business Technology Transfer grant to develop triple negative breast cancer findings into a potential drug.

MUSC Hollings Cancer Center researcher Benjamin Toll, Ph.D., is excited and hopeful about the Cancer Moonshot's focus on smoking cessation.

Interdisciplinary MUSC team wins Blue Sky Award to study the impact of vagus nerve stimulation on hypermobile Ehlers-Danlos syndrome.

MUSC team finds a new, more specific biomarker for a liver cancer type. Currently, no specific diagnostic tools of this type exist for this disease.

With SCTR pilot funding, a bioengineer and vascular surgeon collaborate on potentially heart-saving science.

Will remote trials overcome the barriers that make it difficult for underserved populations to participate in clinical trials? A Hollings researcher weighs in.

A Hollings researcher wants to ID risk biomarkers to enable doctors to stop a serious side effect of stem cell transplant before it happens.

An MUSC Hollings Cancer Center doctor is leading a national trial to test whether drugs used after large B-cell lymphoma returns could instead prevent relapse.

Return to use of opioids after stopping can heighten overdose risk. The McGinty Lab has found a way to reduce return to use in a preclinical model.

As Michael J. Fox shares life story in documentary, including Parkinson’s struggle, an MUSC expert explains the disease, its treatments and hopes for future.

MUSC study identifies a second target for treating depression with transcranial magnetic stimulation.

New treatment approach for babies born dependent on opioids gets them healthy and home faster.

On May 11, Dr. Alex Spiotta will be joined by some of the best and brightest minds in the world of stroke and aneurysm treatment for the first STAR Symposium.

MUSC initiative aims to increase human papillomavirus vaccination rates in underserved communities.

A special course on topics in cancer research for undergraduates at SC State University culminated in a tour at MUSC Hollings Cancer Center.

Dr. Carol Feghali-Bostwick and Dr. ReJoyce Green received prestigious awards at this year's Translational Science conference in Washington, D.C.

How might allowing flavored e-cigarettes or banning menthol cigarettes affect people's tobacco use? The FDA wants a Hollings researcher to find out.

Gain-of-function research became hot topic during pandemic. An MUSC Global Health Week debate looked at pros and cons.

An MUSC Hollings Cancer Center team ID'd a protein that helps cancer cells to navigate the cell division process despite an abnormality that should doom them.

Trial at University of Houston and the Medical University of South Carolina will test treating alcohol use disorder and PTSD together.

MUSC to launch Center of Biomedical Research Excellence focusing on autism, other neurodevelopmental conditions, through $11.3 million NIH grant.

Dr. Michael Cummings was honored for the groundbreaking advances he's made over a 40-year career in tobacco control research.

Electronic health record data can match patients to clinical trials when queries are designed with input from data and clinical experts.

MUSC researchers showed higher numbers of African Americans beginning and completing kidney transplant evaluation after the process was streamlined.

The Charleston Alcohol Research Center at MUSC was recently granted funding from the National Institutes of Health through 2025.

MUSC researchers use a national survey to understand South Carolina’s COVID-19 vaccine hesitancy.

Researchers have found a key gene that links long-term stress to a common depressive symptom, pointing to the need for more personalized depression treatments.

Two small business grants will help Hollings researchers to test new ways to treat acute myeloid leukemia.

Dr. Hamza Hashmi hopes an immunotherapy drug in clinical trials will one day lead to a cancer cure. For now, it's enough to help one woman lead a normal life.

Neuroscientists at MUSC use a novel brain imaging technique to visualize subtle brain changes in pre-symptomatic Alzheimer’s patients.

At just 27-years-old, post-doctoral scholar Cortney Gensemer, Ph.D., has quickly made a name for herself in the genetic research world.

A multicenter study finds that patients with cystic fibrosis can safely take a dual combination of CF modulator drugs for four years.

Using the power of bioinformatics, GI scientists turned cancer researchers find that elevated levels of molecular motor Myo5b are implicated in uterine cancer.

MUSC researchers show that AI can be used to help to identify liver cirrhosis in electronic health records.

MUSC team finds an innovative way to reach more patients with clinical trials.

Innovative study tests trauma treatment for people with HIV to try to ensure they take medication, stay on healthy track.

An MUSC Hollings Cancer Center team has created what members believe to be among the first small molecules designed to stimulate immune cells to fight cancer.

Participation in school-based wellness initiative is associated with decline in average student BMI.

An MUSC Hollings Cancer Center doctor is one of only 12 chosen to participate in the National Cancer Institute’s Early-stage Surgeon Scientist Program.

891 riders and 105 teams raised more than $433,000 to make LOWVELO22 the biggest yet.

MUSC Hollings Cancer Center is investing in its scientists' research, providing pilot grants to help projects to get started.

From the operating room to the board room, we take a behind-the-scenes look at the life of MUSC President Dr. David Cole.

MUSC researchers have discovered a neural circuit that can stop risky behaviors.

A Stand Up 2 Cancer grant will help to ensure that Fetter Health Care patients at risk of lung cancer get the screenings they need.

Katherine Chetta, M.D., and Mindy Engevik, Ph.D., are working together on necrotizing enterocolitis.

Annual walk and fundraiser supports suicide prevention through education and community advocacy efforts.

A type of cell that plays a key role in pancreatic cancer can trace its origin back to a structure that forms during embryonic development.

MUSC Hollings Cancer Center’s Benjamin Toll, Ph.D., is thrilled to be elected to help lead the Society for Research on Nicotine & Tobacco.

A new treatment, dupilumab, is now available to kids with eczema and eosinophilic esophagitis, thanks in part to pediatric clinical trials at MUSC.

Hollings Cancer Center director Raymond N. DuBois, M.D., Ph.D., honored two of the center’s up-and-coming researchers with the High Impact Publications Award.

MUSC researchers and their collaborators will explore how cannabis smoking alters the bacterial communities in the mouth and how those changes affect the brain.

A casual brainstorming session led Hollings researchers to consider how two systems within the body might be "talking" - and enabling cancers to grow.

Playing “serious” games can be an effective and engaging way to teach teamwork and other skills to robotic surgery teams.

With almost 20 years in clinical trials under her belt, Shanta Salzer loves that she can help patients and advance cancer research.

Head and neck cancer survivors often deal with body-image distress. A new cognitive behavioral therapy focused on their unique needs looks promising.

Schiller Surgical Innovation Center embraces AI to enhance decision-making and improve outcomes.

Dr. Anand Mehta has been named a fellow of the National Academy of Inventors, the highest distinction awarded to academic inventors.

Although their immune systems have trouble producing antibodies on their own, a monoclonal antibody protected blood cancer patients from severe COVID.

Medical University of South Carolina researchers show how DNA is packed away when it needs to be turned off.

As the virus has evolved and evidence has accumulated, the COVID-19 toolkit for adults has changed. Learn which tools current research shows are effective.

MUSC honors employees who have reached milestones in their service.

Clinical trials coordinator Alexandria Green falls in love with all her patients. But she's formed a particularly strong bond with one in particular.

A protein that is normally thought of as controlling transcription is actually holding down two jobs, researchers at MUSC Hollings Cancer Center found.

South Carolina is seeing one of the fastest rises in anal cancer incidence among women and anal cancer mortality among men.

For lung cancer screening to work, people need to get scans every year. But a new study shows people don't return for repeat scans.

Science and faith: The Hardys have survived two cancer diagnoses thanks to clinical trials and support from faith, family and friends.

After years of decline in cervical cancer rates, one group of women is now seeing an unexpected increase.

People in rural areas are more likely to smoke and less likely to quit. A Hollings psychologist is using e-visits to reach these smokers and help them to quit.

Riding 100 miles to raise money for cancer required persistence - just like doing research in the lab, says Dr. Leo Ferreira.

After decades serving country in Marines and VA, Robert Hincken donated brain to advance treatments for dementia.

Psychedelics are a buzzy subject these days, with promising clinical trials and celebrity fans. Here’s what a psychiatrist says you need to keep in mind.

Everything came together to make LOWVELO22, raising funds for cancer research at Hollings, a resounding success.

All the advances in cancer care don't help if people can't get to appointments. A paper lays out the issue of transportation insecurity for people with cancer.

Medical student helps IP course improvements.

'Nice guy' researcher's pioneering colon cancer work could have implications for other cancers.

Veteran who tried technology-based treatment for PTSD in clinical trial at MUSC says it made “night and day difference.”

Unique collaboration builds equity into the fabric of care and research at MUSC.

Doctors at MUSC Hollings Cancer Center say that colonoscopies remain an important screening tool, question results of recent study.

A Hollings immunologist is investigating how a protein might alter a person's immune response and gut microbiome, contributing to colon cancer.

Breast cancer researcher develops new drug candidates, nearing clinical trials.

MUSC research leader believes curiosity creates cures and is bringing together scientists to open new avenues of discovery.

Hollings researcher Joe Delaney is one of 72 recipients of the NIH director’s New Innovator Award, which funds unusually creative early-stage investigators.

When you need to address public health emergencies quickly, it’s sometimes best not to reinvent the wheel.

MUSC researchers show that patients with scleroderma and lung fibrosis, or scarring, have too little of the antifibrotic protein Cathepsin L.

MUSC Hollings Cancer Center is promoting entrepreneurship among its researchers.

The Atlantic Hurricane Season is reaching its peak. There's still time to prepare.

Ashish Deshmukh, Ph.D., was drawn to the Cancer Control program at Hollings by its collaborative spirit.

A pilot study will measure circulating tumor DNA in cancer patients with 'extraordinary' response to immunotherapy.

Study led by researchers at MUSC found high levels of depression, PTSD and “large unmet mental health need” following Flint water crisis.

With a grant from The Duke Endowment, a new project at MUSC Hollings Cancer Center has ambitious goals to increase screening rates for five cancers.

A Hollings researcher has received two grants aimed at early career investigators to help advance his breast cancer research.

A summer in a research lab might change one Charleston County high schooler's career path.

Consider "place, space and ancestry" when investigating health disparities, said the keynote speaker at a cancer health equity symposium at Hollings.

Peggi Angel, Ph.D., is looking at whether glycosylation regulation may be influenced by socioeconomic stressors and contribute to breast cancer disparities.

An MUSC Hollings Cancer Center researcher is among the first to use a new device meant to improve Treg gene editing.

Some dreams can be magical. Others confusing. But most have some element of mystery. Dr. Thomas Uhde has always been fascinated by the science behind them.

A national study is assessing whether online courses on pain management can help cancer patients.

A clinical trial at MUSC Hollings Cancer Center will investigate if a common statin could lead to a stronger anti-tumor response in prostate cancer patients.

Early career researcher at Hollings awarded grant by Pancreatic Cancer Action Network.

She's been known as an innovator in instructional technology, an educator, a leader and mentor to faculty, staff and students.

Jezabel R. Blanco is determined to find better treatments for children with medulloblastoma.

Newly combined institute looks to take health care improvements from concept to reality more quickly.

Hollings researchers are testing combinations of drugs used for conditions including HIV and diabetes to instead fight cancer.

When MUSC researchers collaborate and combine their expertise, technologies and passion, they tap into a special kind of energy.

Patient Marty Perlmutter says the CAR-T-cell therapy he received for cancer is like science fiction has become reality.

Disparities advocate, adviser and humanitarian is celebrated for 37-plus years of service to MUSC.

Integrated tool will allow clinical trial enrollment and cost effectiveness to be tracked across the health system

A new initiative at MUSC Hollings Cancer Center aims to improve survivorship care for cancer patients.

Blue Sky Award winners endeavor to restore vision in patients with age-related macular degeneration by recharging cells’ batteries.

A new joint program at MUSC and Clemson University will offer training in how to harness big data to identify and address health inequities.

A Hollings researcher is investigating how yogic breathing may help cancer patients’ quality of life and health.

If Clearview Surgical and Dr. Marc Katz have their way, AR could be the future of surgery in the not-too-distant future.

A clinical trial gave one melanoma patient access to cutting-edge treatment before the medication came to market.

The vaccinia virus uses the same tool to copy and repair DNA and blocking that tool dramatically reduces the virus’s ability to multiply, MUSC study finds.

Ambulances equipped with cutting-edge scanners could lessen the time it takes to get stroke patients the treatment they need.

Every year artificial intelligence becomes more intertwined with health care. Some of the areas top AI minds got together to discuss how to take it further.

In a highly competitive event, MUSC employees pitched innovative ideas in “Shark Tank” showdown. Three concepts got judges to bite.

Stroke research improves when survivors and caregivers feel comfortable telling their stories and researchers learn to listen.

MUSC researchers created a model to find treatment options for a type of brain bleed in premature babies.

Noted Alzheimer’s researchers at MUSC weigh in on the recent discovery of 42 new Alzheimer's genes and discuss what it means for the future of research.

Dr. Jason Newman brings passion, expertise and big ideas to his new role leading head and neck oncology at Hollings.

Study of data from NASA, ESA and Russian space agency explores effects of extended spaceflight on brain.

Dr. Raymond N. DuBois received the Distinguished Service Award during the opening ceremony of the 2022 AACR convention.

Doctors at MUSC Health are excited to participate in a trial demonstrating a less invasive way to implant a heart failure device.

Dr. John Rhodes has never been comfortable talking about his dyslexia. But he decided to speak at TEDxCharleston to show that academic success is possible.

Dr. Shikhar Mehrotra's team has found a new approach that shows promise of boosting the long-term success of T-cell therapy.

A two-day conference at MUSC sought to bring awareness of LGBTQ health issues to health care providers, students and researchers.

Researchers, doctors, patients and donors gathered to celebrate the progress in researching Ehlers-Danlos syndrome.

MUSC researchers have developed a way to remove toxic chemotherapeutic drugs from the blood after cancer treatment to prevent them from reaching the heart.

Dr. Angela Yoon brings her expertise on biomarkers and immunotherapy to the Hollings head and neck cancer team.

A Hollings researcher helped develop a new program to increase smoking cessation efforts in 1,500 national cancer centers.

The keynote speakers at Translational Research Day will discuss their journey into research and clinical care for EDS patients.

Hollings researcher Leonardo Ferreira, Ph.D., is driven by the passion to make chimeric antigen receptor (CAR)-T-cell therapies safer and more widely available.

A Hollings clinical trial for HPV-related head and neck cancer is showing promising results.

In public health and school nursing, Kasey Jordan saw smart people stymied by the system. That led her to get her PhD and study innovation management.

Hollings received its first Stand Up to Cancer grant that will make it part of a group addressing lung cancer disparities.

Dr. Edith Williams has made giving suffering women hope her life’s work, “making the invisible visible.”

In Alzheimer’s disease, fewer cells line the brain's smallest vessels, making them leaky. Blocking a protein stopped the leakage and improved memory in mice.

Glenn Bachmann is helping to move the science forward by participating in a clinical trial at Hollings in the hopes of helping other patients.

New device being tested at MUSC is designed to calm the cytokine storm in patients with COVID-19 and kidney failure.

SCBIO honors MUSC with Life Sciences Pinnacle Award for Organizational Contribution.

Vascular surgeons are using a device that uses sonic pressure waves to break up calcifications that are blocking blood vessels.

A trial studying already-approved drugs to now be used against COVID-19 opened an arm to test a different dosage of the antiparasitic drug ivermectin.

A new non-invasive technique pioneered at MUSC provides a near-real-time view of the human brain’s waste-clearance vessels.

An MUSC Hollings Cancer Center study sheds light on better ways to prevent and treat colorectal cancer.

New study sheds light on how doctors have been treating children with severe COVID-19.

Hollings researcher Sophie Paczesny, M.D., Ph.D., received a grant to help doctors to fight complications after pediatric bone marrow transplantation.

Hollings researcher John O’Bryan, Ph.D., and colleagues have demonstrated a new therapeutic way to block a protein that is frequently mutated in cancers.

Employees put their best foot forward and are being celebrated for embodying values that are important at MUSC.

Researchers publish a roadmap for rolling out a COVID-19 exposure notification mobile app at a large public university in South Carolina.

Hollings researcher Sophie Paczesny, M.D., Ph.D., received a $628,188 grant from the National Cancer Institute to improve graft-versus-host disease treatment.

Rena N. Grant Sickle Cell Center at MUSC honors inspiring woman as it tackles ambitious goals.

MUSC Health contributes to study showing that COVID-19 vaccines are effective in keeping teens out of the ICU.

New cloud--based platform will lead to improvements and efficiency around MUSC.

Four Hollings researchers received grants from the American Cancer Society to support their work on promising projects.

MUSC Children's Health contributes to study showing vaccination is effective against MIS-C.

MUSC research team has identified a pathway by which a known antifibrotic protein works, providing a possible clinical solution for patients with fibrosis.

Newly approved treatments and more cervical cancer clinical trials on the horizon have Hollings doctors optimistic.

The longer astronauts stay in space, the more they report blurry vision and eyesight problems when they return to Earth. But why?

More than $1.8 million was raised for the Medical University of South Carolina as a part of Giving Tuesday.

The collaborative biorepository project between MUSC and SCSU is expanding with the hopes of reaching more medically underserved communities.

Performing an MRI en route to the hospital could cut treatment time for stroke patients. But is it even possible?

Research from MUSC’s Digestive Disease Research Core Center suggests that doctors can fail to diagnose alcoholic cirrhosis if they rely only on lab results.

Wearable technology allows therapists to “accompany” PTSD patients virtually during exposure therapy and use real-time psychophysiology to improve outcomes.

The Boeing Center for Children’s Wellness school-based wellness intervention offers schools a menu of wellness initiatives they can tailor to their own needs.

For the past three years, Stanford University has named the top 2% of scientific researchers. This year, MUSC saw 134 of its faculty make the elite list.

Hollings researchers are part of a new global study that will examine different regulatory approaches to tobacco products.

MUSC pediatricians contribute to nationwide study that finds Pfizer’s COVID-19 vaccine effective against hospitalization in children age 12-18.

The Charleston Metro Chamber of Commerce honored MUSC President David J. Cole, M.D., FACS, for his leadership during the pandemic.

A Hollings researcher attended the first U.K.-U.S. scientific summit with more than 60 other leading cancer research experts.

A new study estimates that over 5,000 cancer deaths were prevented in early Medicaid expansion states during the study period.

State funds make up less than 4% of MUSC’s annual budget. That’s why Giving Tuesday is so important to MUSC.

Hollings researcher Dr. Leonardo Ferreira is exploring ways to use regulatory T-cells to treat a range of autoimmune problems.

The Canadian Partnership Against Cancer reports that it’s increased the number of smoking cessation services in Canada to 87%.

A new way of doing CT scans means less radiation and better images - and MUSC researchers are helping to fine tune the technology.

Participants braved the cold and wind to celebrate LOWVELO21 and its cause: raising money for cancer research at Hollings.

At SCTR’s recent retreat, NIMHD director and South Carolina scientists discussed the way forward for health disparities research.

Adults with maltreatment-related posttraumatic stress disorder or with a history of sexual abuse have reduced brain connectivity. Oxytocin can help.

First lady Dr. Jill Biden promotes health equity and breast cancer awareness during a visit to MUSC Hollings Cancer Center.

A decrease in the activity of proteins involved in liver scarring after hepatitis C treatment could suggest a path toward healing of cirrhotic liver tissue.

A new partnership between Clemson and MUSC has its sights set on using artificial intelligence to improve health care.

The Medical University of South Carolina sets extramural funding record with help of COVID-related money.

Drs. David Turner and Victoria Findlay secured a $228K grant to find if advanced glycation end products in pet food cause cancer.

Science communications internship in the College of Graduate Studies helps scientists in training to share research with the general public.

Hollings researchers Dr. Wenjian Gan and Dr. Tracy Smith are the first winners of Hollings' High Impact Publications Award.

Hollings is part of a prestigious national grant that will address lung cancer disparities using a collaborative approach.

Hollings researchers use imaging technology to identify liver cancer subtypes based on the sugar structures on tumors.

Hollings researchers are studying the rise of colorectal cancer in young people and why minorities are more vulnerable.

A clinical trial is enrolling people with mild COVID-19 to see if any of three existing drugs work against the disease.

According to a new population-based study, researchers attributed over 700K new cases of cancer in 2020 to alcohol consumption.

Hollings director appointed to international working group dedicated to supporting cancer prevention research.

Hollings taking part in study to improve the delivery of patient-centered care for head and neck cancer survivors.

Older patients with nontuberculous mycobacterial lung disease are hospitalized sooner and more often than their counterparts without the disease.

Hollings researcher Dr. Michael Cummings won a prestigious award for his major contributions connecting smoking and disease.

MUSC neurologist will co-lead the CAPTIVA trial, which will enroll 1,683 participants with a narrowed brain artery across 115 U.S. sites.

Transplant surgeon argues that new kidney allocation system unfairly impacts patients in rural areas.

Hollings researchers found a mechanism showing how gene mutations allow tumors to evade detection in colorectal cancer patients.

The Telehealth Service Implementation Model (TSIM) is a roadmap for navigating the complexities of establishing a strong and durable telehealth program.

Hollings researchers received a grant from the DoD to investigate how dietary fat affects the development of colon cancer.

MUSC innovator’s company uses DOE-developed microsphere technology to create a new oral drug delivery system.

Children can develop neurological disorders from COVID-19 & for some, they can be life-threatening.

Everyday Everest founder Cokie Cox summited Mount Everest, raising critical funding for cancer research at MUSC Hollings.

MUSC researchers discover a potential biomarker that predicts severity of heart disease in African American lupus patients.

MUSC Hollings will glow blue the week of Aug. 30 at the start of LOWVELO’s Glow Blue Week to celebrate the LOWVELO 2021 ride.

Scans revealed the presence of infiltrates, a lung scan’s hazy gray area, serves as a marker of COVID-19 prior to symptoms.

With COVID variants spreading quickly, health experts urge cancer patients and families to take caution with rising numbers.

Diversity in clinical trials makes medicine safe for everyone.

Measuring circulating blood levels of a specific lipid, allows clinicians to predict whether COVID-19-positive patients will develop symptoms.

Climate scientists are in Charleston to record temperatures and understand the risks of extreme heat.

A bench-to-bedside-pioneered lung cancer immunotherapy developed at MUSC Hollings to be offered in NCI clinical trials.

MUSC Hollings Cancer Center hopes to save lives by expanding the Tobacco Treatment program to rural, underserved communities.

MUSC researcher is awarded NIH funding to refine artificial intelligence algorithm to identify those at risk of suicide.

Brian Hess, M.D., a Hollings researcher and lymphoma specialist, was key in bringing a lymphoma clinical trial to Hollings.

Cancer survivor Jana Chanthabane turns tragedy into triumph while raising money for cancer research in Swim Across America.

Richard Gadsden reflects on the evolution of computing technology that he's been part of in 43 years at MUSC.

A new team at MUSC Health aims to help more people across the state survive cardiogenic shock – a rare but life-threatening condition.

Influenced by world events, MUSC vice chair for Academic Programs teaches students and educators about the importance of adopting a global perspective.

MUSC researchers believe they have found a gene mutation associated with hypermobile Ehlers-Danlos syndrome.

Immigrants bring fresh perspectives that enrich cultural, intellectual and scientific pursuits but often face obstacles.

Hollings researchers are studying how a new medicine could give blood cancer patients a better shot at remission.

MUSC Shark Tank participants are celebrated.

Black individuals of African ancestry are approximately 30% of S.C.’s population and are disproportionately affected by HNC.

The FDA is moving to ban menthol cigarettes and flavored cigars in the U.S. and sparking hope for smoking cessation advocates.

Anyone can now take innovative ideas to the next level.

Doctor who has tested controversial new Alzheimer’s drug with patients calls it exciting - but urges caution.

Personal loss inspired a Hollings researcher to apply breast cancer findings toward a potential new osteosarcoma treatment.

Largest study to date analyzes medical treatments for preschool-age children with attention deficit hyperactivity disorder.

A multidisciplinary Hollings team is collaborating on a project to make CAR-T-cell therapy safer and more effective.

MUSC research could help scientists to understand why some liver cells do not develop correctly in children with inherited liver diseases.

Cis P-tau is an early driver of Alzheimer’s disease and related dementias; silencing this protein ameliorates dementia symptoms in preclinical models.

Researchers at MUSC and elsewhere find a new antibiotic regimen that shortens the treatment course for patients with TB.

Dr. Besim Ogretmen and his research team found a new link between aging, metabolism and anti-cancer T-cell function.

Hollings researcher Dr. Jen Wang was awarded a $225,000 Young Investigator grant from the Melanoma Research Alliance.

MUSC neurologists are the first to develop a preclinical brain cancer model using cutting-edge BrainPath technology.

Hollings researchers have discovered a more efficient way to enhance gene silencing for potential use in cancer drugs.

COVID-19 researchers from across S.C. talk treatments, variants, vaccines and more at SCTR-sponsored retreat.

Hollings researcher finds that older Medicare beneficiaries have better lung cancer outcomes than younger uninsured patients.

Black woman scientist excels on the bench as well as at home raising two children.

Hollings researchers find that asymptomatic individuals had stronger antibody responses to COVID-19 versus symptomatic patients.

Health care is ever evolving – and the annual MUSC Shark Tank innovation pitching session is a chance for employees and students to push that evolution along.

Girls with mutations in the gene EPHB2 may be at increased risk of autism.

Roughly 40% to 50% of people with HIV smoke, so Hollings researchers are studying ways to improve tobacco treatment delivery.

Physicians at MUSC Health partner with Georgetown Hospital to significantly shorten time between a patient’s stroke and treatment using telehealth.

Hollings is enrolling patients in a national clinical trial to compare radiation therapy treatments for prostate cancer.

Children living in rural America are less likely to receive preventive dental care than those living in cities.

This week Dr. Scheurer talks about how switching strategies is the key to overcoming vaccine hesitancy.

MUSC Presidential Scholar students found innovative ways to stay busy throughout the pandemic.

A new digital platform facilitates information sharing about clinical studies across disparate systems.

Technology developed by Hollings researchers can detect early-stage liver cancer at double the rate of current tools.

A new study by Hollings researchers shows that more than 60% of U.S. adults who vape are interested in quitting.

Dr. Scheurer talks sharing vaccine recipes, kid trials and much more in this week's Q&A.

When we left off, Kelly Warren had just had her second shot in a vaccine trial. Now, she finds out if it was the real deal.

Registration opens March 24 for LOWVELO, Hollings' annual bike ride to raise money for lifesaving cancer research.

Hollings is partnering with the Talbot family to bring a state affiliate of the Pancreatic Cancer Action Network to South Carolina.

MUSC team reports in Pediatrics that the first two kids in nation treated with an investigational therapy for MIS-C improved dramatically within a day.

MUSC researchers provide preclinical evidence that mental losses after TBI can be reversed with complement inhibition.

Women’s History Month finds women at the Medical University of South Carolina reflecting on the fact that they’re living through history.

A recent successful clinical trial for a drug to help people lose weight is one of many programs at the MUSC Health Weight Management Center.

MUSC researchers prove motor cortex is successful target for pain and addiction treatment, which suggests an overlooked area of the brain in TMS treatment.

Hollings researchers aim to generate awareness about lung cancer screening disparities in order to improve treatment outcomes.

MUSC researcher awarded a 10-year, $9.9 million contract by the CDC to conduct clinical trials for the Tuberculosis Trials Consortium.

A radiology artificial intelligence program proved so useful that the technology will now be used across the MUSC Health system.

A new paper published by Hollings researchers reveals a potential new approach for reducing graft-versus-host disease.

Hollings researchers discovered that a single strain of bacteria significantly reduced graft-versus-host disease.

A nationwide study hopes to gain insight about COVID-19 in cancer patients and how treatment outcomes are affected.

Vaccine trial volunteer Kelly Warren wonders what's next now that she's had 2 shots. Will her participation affect her chance of getting an approved vaccine?

Mulugeta Gebregziabher, Ph.D., has spent his professional career focused on making the world a better place. Today he's asking the world to return the favor.

She's getting her second shot in a COVID-19 vaccine trial. Will there be side effects again?

Patrick Flume, M.D., who leads the new Novavax and Janssen vaccine trials, answers questions that potential participants might have.

Tracers that track tau and amyloid, two key markers in Alzheimer’s disease, can be used to monitor disease progression in the brain.

A brain cancer diagnosis gave Claudia Salazar even more motivation to make an impact in cancer research and health disparities.

An MUSC team received national recognition for the Matrix, a tool that helps to ensure successful recruitment and retention of clinical research professionals.

Large-scale research sheds new light on nonfatal firearm injuries and interventions.

Farming peptides in plants could mean cheaper, better treatments for the scarring that leads to organ failure in many diseases.

MUSC leadership previewed OneMUSC, the new roadmap that will guide the vision for every individual at MUSC.

As people wait for their turn to get COVID-19 vaccine, MUSC tests two possible alternatives.

Even after accounting for factors associated with bad behavior, researchers found Black elementary children more likely to be suspended than white children.

A Hollings clinical trial is testing the impact of changing the order of treatments for metastatic prostate cancer patients.

Dr. Elizabeth Hill has joined MUSC Hollings Cancer Center as the new director of the Biostatistics Shared Resource.

Some experts feared in-person school during pandemic would cause surge in cases. Data show that hasn’t happened in Charleston County.

A portion of the proceeds from this year's Head for the Cure Charleston 5K will support brain cancer research at Hollings.

A product conceived of by MUSC Health clinicians, developed by ZIAN engineers and now manufactured by Rhythmlink will make the operating room a safer place.

Marine veteran Tony Pesavento survived multiple battles with larynx cancer and credits a clinical trial with saving his life.

Almost 100 people have signed up so far for an MUSC survey that could help Charleston as it tries to bring COVID-19 under control.

Hollings researchers are testing a new prostate cancer drug that may help patients who stop responding to standard treatments.

Vaccine trial participant has a follow-up appointment, "trying not to get cocky and think I’m now super-human."

It turns out vials of the Pfizer-BioNTech COVID-19 vaccine – each of which was supposed to contain five doses – has as many as one or two more in them.

Vaccine trial participant doesn't know if she got the vaccine but she does know she's got chills - and they're multiplying.

MUSC received its first shipment of the Pfizer COVID-19 vaccine on Tuesday. In less than three hours of receipt it was going in the arms of front line workers.

COVID-19 vaccine trial participant describes the day she gets her first shot. Is it the real deal or a placebo?

MUSC will receive its first wave of COVID-19 vaccines from Pfizer the week of Dec. 14.

When diagnosed with leukemia, MUSC Health-Charleston CEO David Zaas benefited from a clinical trial. He wants all MUSC patients to have the same opportunity.

Vaccine trial volunteer writes about her decision to participate in COVID-19 research.

The Office of Innovation celebrates excellence with September 2020 MUSC Innovators.

Dr. Nancy Klauber-DeMore receives notable distinction for her academic innovation in cancer research and impact on patients.

Hollings researchers study how, why, and how often patients use marijuana to relieve cancer symptoms and side effects.

MUSC study uses noninvasive technique to stimulate vagus nerve and reduce inflammation in people with neuropsychiatric symptoms post-COVID.

Speakers at MUSC’s fourth annual Inclusion to Innovation Summit offered motivation and hope.

MUSC researchers show that lysyl oxidase plays several important roles in promoting fibrosis in scleroderma and could be a biomarker of treatment response.

People can show their support for MUSC's mission in three ways this Giving Tuesday: by donating, as an ambassador or by hosting a fundraiser.

With Zeriscope’s Teletrainer, remote experts can train doctors anywhere to detect stroke risk in kids with sickle cell disease.

Preeclampsia-related gene expression in the placenta may correlate with vitamin D status during pregnancy.

To create a one-stop telehealth solution, Ignis Health, with its own telehealth analytics platform, licensed a roadmap for telehealth implementation from MUSC.

Amy and Lucy Krasker donated to the COVID-19 biorepository because they knew their donations could provide exponential returns for research into the disease.

Hollings researchers discover a way to reduce graft-versus-host disease while maintaining T-cells' ability to kill leukemia cells.

MUSC is working with Charleston to measure COVID’s spread and gauge attitudes about prevention efforts and vaccines.

Ellen Steinberg thinks her mother would be smiling if she knew something good might come from her difficult final days of life.

Hollings researchers find a new way to generate T-cells faster, making immediate treatment with this therapy possible.

Drug cues change the connectivity between brain cells, making it harder to stop seeking drugs.

Organizers say the Inclusion to Innovation summit is more important than ever in this year of COVID-19 and national protests.

MUSC Hollings Cancer Center researchers collaborate across disciplines to improve breast cancer prevention measures, diagnostic tools, and treatment options.

Researchers are working to understand why neurons respond more strongly to drug cues than cues for natural rewards, like sugar.

An MUSC Hollings Cancer Center Phase II clinical trial will examine the safety and efficacy of a new combination of drugs for treating a rare form of lymphoma.

Spinal cord injury researchers continue to make progress in aging and quality of life research for people.

MUSC researchers use deep learning models to identify patients at risk of intentional self-harm based on unstructured patient clinical notes alone.

The Bonilha lab at MUSC is working to better understand the complexity of brain networks, and along the way to help people with aphasia and epilepsy.

Hollings researchers discover a new biomarker whose activity can be blocked to prevent graft-versus-host disease following stem cell transplantation.

As space missions are planned, researchers advocate for more unified protocols.

As President Donald Trump quarantines with COVID-19, an infectious disease expert describes risks and care he could receive.

A collaboration between MUSC and the University of Sydney is yielding new insights into how alcohol affects the developing brain.

Expert on bradykinin hopes trials will show attacking it with 2 medicines already approved by FDA can help fight lung problems linked to COVID-19.

New tech is just the beginning with a new affiliation with Synaptive. MUSC doctors will have a hand in developing uses for this tech.

As part of a translational research training program, biomedical science students shadow clinicians to learn more about the patients whose diseases they study.

How does zero gravity affect astronauts' brains? MUSC scientists took to the skies as they try to figure that out.

MUSC’s new chair of public health sciences is honored to appear on national list of inspiring Hispanic/Latinx scientists.

Gruthan Bioscience was recently awarded funding to develop a novel class of cholesterol-lowering drugs to treat a rare form of familial hypercholesterolemia.

Hollings researcher Dr. Nancy Klauber-DeMore played a vital role in the FDA granting rare pediatric disease designation for a new osteosarcoma treatment.

MUSC researchers find that variation in just three brain genes predicts how well a medication will work in treating a patient with alcohol use disorder.

Hollings researchers work to understand and target the barriers that lead to treatment delays in head and neck cancer patients.

Dr. Chanita Hughes-Halbert took part in the virtual congressional briefing that unveiled a first-of-its-kind cancer disparities report to the nation.

Researchers have found a way to create a highly-accurate saliva test for COVID, thus making it much easier on patient and provider.

COVID-19 has severely disrupted services and structure that children with autism need. Parents are getting creative.

Dr. Denis Guttridge shares lessons learned from turning the 2020 Cancer Cachexia Conference into a virtual event.

MUSC Health rapidly adapted telehealth technologies to meet the needs of its patients during the pandemic.

The number of new COVID-19 cases in the Tri-county area is down again, bringing key indicator closer to getting out of red zone.

Peggi Angel, Ph.D., received a $3 million National Cancer Institute grant to study the role of collagen in breast cancer health disparities.

A new fleet of MUSC-developed technologies enables patients across the state to participate in smoking cessation and other clinical trials remotely.

A 3D metal printer at the College of Dental Medicine is sparking collaborations across campus.

An interdisciplinary MUSC team has identified a critical player in resistance to targeted therapy in lung cancer.

Dr. Jezabel R. Blanco received a prestigious $300,000 research award from the Rally Foundation to support her work on pediatric brain cancer.

Four-year-old patient at MUSC Shawn Jenkins Children’s Hospital becomes first child to get experimental treatment for life-threatening MIS-C.

MUSC researchers found almost half of people between 12 and 17 who vape have thought seriously about quitting.

Along with AstraZeneca and IQVIA, MUSC was selected be part of a Phase III trial of a vaccine that has shown promise in battling COVID-19.

The newly reopened adult burn center at MUSC Health team performed the first reported successful minimally invasive skin graft on a burn in the U.S.

Jezabel Blanco is one of only two recipients of a $300,000 grant from the Rally Foundation for pediatric cancer researchers at the beginning of their careers.

Governor bestows highest civilian honor on Dr. Dean Kilpatrick for his decades of research and advocacy for trauma survivors.

FDA approves the Guardian Needle, a solution created by MUSC Health clinician-innovators to reduce accidental needle sticks during intraoperative monitoring.

The smallest victims of the opioid crisis are babies born dependent on opioids. A clinical trial is seeking to ease these little ones' withdrawal symptoms.

A database created by MUSC investigators is a resource for researchers to develop a deeper understanding of breast cancer cell lines and potential therapies.

New registry will help track the pandemic, identify effective treatments and unleash the predictive powers of AI.

MUSC is part of a national trial to study convalescent plasma in an outpatient setting.

MUSC researchers Chanita Hughes-Halbert, Ph.D., and Anita Ramsetty, M.D., recently received a grant for work with social determinants of health.

The Medical University of South Carolina is recruiting people with COVID-19 for a trial testing a potential antibody treatment.

The role of masks in controlling COVID-19 spread is becoming clearer as we learn more about the novel coronavirus.

Hollings Cancer Center researcher Jessica Thaxton, Ph.D., received two grants to further her work on the stress that immune cells face when fighting tumors.

A new volume of cancer health equity research coedited by Hollings Cancer Center’s Marvella Ford, Ph.D., identifies potential solutions to address disparities.

MUSC researchers find link between mental imagery and vision using artificial intelligence and human brain studies.

MUSC team is one of nine chosen by U.S. Army to build a prototype for increasing ICU surge capacity during COVID-19.

MUSC's NC NM4R has taken a leadership role in the realm of rehabilitation research.

MUSC researchers have formulated a vitamin K-based compound that eliminates medication-resistant epileptic seizures in mice tested to date.

Two MUSC experts covered a range of questions about COVID-19, from progress toward a vaccine to doubts about whether there is truly a spike in local cases.

MUSC research team has developed a technology that takes aim at COVID-19's sugar coating to predict which patients will develop serious illness.

The Shark Tank competition is an opportunity for the MUSC community, at all levels, to present their ideas to leadership. The 2020 session didn't disappoint.

Two MUSC researchers will talk about the latest coronavirus pandemic news during a public forum June 30.

Blood and saliva sample donations from COVID-19 patients will help researchers understand the body's immune response to the novel coronavirus.

MUSC Health expands COVID-19 clinical trials to regional hospitals.

Researchers at MUSC and Clemson University have developed human cardiac organoids to model heart attack and drug cardiotoxicity.

HCC researchers published a study showing an increased risk of breast cancer in women who ate a diet high in processed foods.

Clinical trials can make a big difference in patients' lives, but COVID-19 forced a halt to many. MUSC Health recently resumed one trial of a COPD treatment.

Two studies highlight the importance of chronic disease prevention and management to help reduce the impact of health disparities.

The recent openings of two centers have put MUSC on the map as a leading institution for digestive and liver disease research.

HCC researchers are launching a clinical trial to study a new treatment combination for pancreatic cancer.

Adding a compound to reduce inflammation to standard stroke treatment could improve cognitive recovery and extend treatment window, preclinical study suggests.

The latest data from a multinational research consortium shows that cancer patients face greater negative impacts from COVID-19.

MUSC team examined an antibiotic-resistant strain of Neisseria gonorrhoeae and found a surprisingly new resistance mechanism that inhibits protein dynamics.

Battling COVID-19 effectively will require a freer flow of data, argues an MUSC researcher. Federal office issues clarifications to make that happen.

Dr. Paula Traktman, a noted virologist and Dean of the College of Graduate Studies at MUSC, answers questions about COVID-19.

Hollings Cancer Center researchers have developed a technique that could help lead to improved cancer killing ability in T cells.

Hollings Cancer Center awarded funding to five scientists as part of its fellowship program to train the next generation of cancer researchers.

Timmy Samec, a cancer researcher and patient, is the first LOWVELO graduate fellow at Hollings Cancer Center.

Veteran vitamin D researchers at MUSC gear up to study whether “sunshine vitamin” can play role in fighting COVID-19.

Hollings Cancer Center researchers have developed nomogram prediction tools to help improve head and neck cancer care delivery and patient outcomes.

The majority of MUSC health care workers in the first week of testing showed no antibodies to COVID-19.

Researchers at Hollings Cancer Center are developing a clinical trial involving the use of T cells, normally a part of cancer treatment, to fight COVID-19.

From front line doctors and nurses to cleaning crew, heroes of pandemic are asked to share experiences in national registry.

A collaboration between MUSC scientists and the Greenwood Genetic Center leads to new findings about a rare neurodevelopmental disorder.

Some people are charmed. Others cursed. For Johan Zamoscianyk, there’s more nuance to it. It’s almost as if he’s charmed by curse.

A startup company formed by Hollings Cancer Center researchers has been awarded a grant to advance its novel adoptive cell therapy technology.

Medical intern burnout is driven by the same factors as depression.

As cases of COVID-19 continue to rise across the country, African Americans have emerged as those at the highest risk for contracting the illness.

Scientists from the state's three research universities are working together to build a SARS-CoV-2 antibody test to ensure one is available to South Carolinians

Shikhar Mehrotra, Ph.D., and Sophie Paczesny, M.D., Ph.D., named new co-leaders of the Cancer Immunology program at Hollings Cancer Center.

MUSC is working to develop a biorepository of COVID-19 samples that will be available to researchers.

Deploying artificial intelligence could help radiologists to more accurately classify lung diseases.

MUSC Health will be part of a large, national trial testing effectiveness of hydroxychloroquine for COVID-19 patients.

MUSC researcher will gather evidence to optimize an important pediatric swallow study.

The unique intersection in the brain between the stress system and binge drinking may be the key to controlling the urge to binge drink.

Researchers are looking to health care workers to help better understand the body's response to exposure of the novel coronavirus.

Learn more about headline-making drugs in the fight against COVID-19 in this Q&A with Patrick Woster, Ph.D., a leading expert in drug discovery research.

MUSC College of Medicine student Shannon McGue writes about her Fulbright-Fogarty Fellowship and the impact of COVID-19.

Researchers are testing new strategies to improve head and neck cancer patient survival and decrease racial disparities in outcomes.

From the FBI down to the local level, internet security experts across the board are on the lookout for cybercriminals taking advantage of the pandemic.

MUSC study suggests transcranial magnetic stimulation is safe and could reduce depressive symptoms in adults with autism and depression.

MUSC study shows that the natural product derived from IndoPacific marine sponges has anticancer properties

MUSC Health at the Medical University of South Carolina has become the first hospital/medical center in the state capable of doing its own COVID-19 testing.

Study involving MUSC researcher finds that states participating in Medicaid expansion are seeing more timely diagnoses for head and neck cancers.

With the funding, SCTR will further grow the state's translational research infrastructure and ensure that research findings benefit all its residents.

Researchers at MUSC have discovered the therapeutic potential of a class of lipids to prevent memory loss in a Down syndrome preclinical model.

MUSC offers first-known combo of telehealth screening and drive-through specimen collection to address potential exposure to and spread of the coronavirus.

It's an exciting time to work in cystic fibrosis, says MUSC Health Dr. Patrick Flume, thanks to new treatments that have extended patients' lifespan.

The potential mechanism of how blood clotting contributes to cancer growth has been discovered.

Study participants want to know trial results, and researchers want to tell them but lack lay communication skills.

MUSC researcher stubbs out one misconception about the effect of low-nicotine cigarettes.

MUSC Health’s Comprehensive Stroke Center team is celebrating a big milestone – the 1,000th patient treated with the ADAPT procedure.

Foundation for Research Development's mission: to multiply MUSC's impact across nation and increase recognition of work done here.

An MUSC study could lead to paradigm shift in care for teenagers suffering from both PTSD and substance use issues.

Interhospital transfer may be essential for the sickest patients, but their risk of death is higher than that of patients admitted via the emergency department.

An MUSC researcher looks into using artificial intelligence to help rural patients and their doctors assess hereditary cancer risks.

An MUSC researcher found giving smokers a free starter kit of nicotine replacement therapy at their annual doctor visit increased their odds of quitting.

Visiting scholars at MUSC from China are raising money to help colleagues in Wuhan battle coronavirus.

Getting pregnant while on opioids is a serious concern. MUSC research may ensure more women get the right help.

People who break a rib typically must live with pain until it heals. A study showed surgically stabilizing the ribs meant less pain and fewer complications.

MUSC Office of Innovation presents 2019 fourth quarter innovator awards.

Portable, lightweight device for measuring the natural blink reflex receives FDA approval.

As Dr. Gustavo Leone steps down as director of MUSC's Hollings Cancer Center, Denis Guttridge, Ph.D., assumes interim role to ensure smooth transition.

MUSC researchers believe copper could be a hospital’s savior and a bacteria’s worst nightmare.

MUSC researchers have found gender-based differences in response to therapeutic oxytocin in cocaine-addicted individuals with childhood trauma.

InDepth Pharmaceuticals signs agreement with the MUSC Foundation for Research Development to evaluate kidney diagnostic to predict kidney transplant success.

Four researchers at MUSC have been awarded a patent for their idea of a nanoparticle that delivers anti-rejection drugs directly to an organ pre-transplant.

The primary focus of smoking cessation research in the past has always been adults, but a new study in JAMA Pediatrics zeroes in on adolescents.

MUSC startup receives NIH funding to develop compounds to prevent one of the most common causes of organ rejection after transplant.

Hollings researchers have received funding from the NCI to support three new research projects under SC CADRE.

MUSC-based mass violence center tackles surprising issues - including the Flint water crisis.

MUSC researchers are looking at changes in the underlying mechanisms in the brains of opioid abusers in the hopes of one day finding a way to prevent relapse.

MUSC researchers report in Gastroenterology that a signaling molecule involved in inflammation promotes colorectal cancer progression.

MUSC was recently designated as an ALS Certified Treatment Center of Excellence Program. It becomes the first center of its kind in the state.

When it comes to predicting heart disease in African Americans, measuring cholesterol is not enough. Sphingolipid levels could one day hold the key.

MUSC Health now owns the first robotic bronchoscopy machine in South Carolina, able to safely diagnose small lung cancer nodules.

Five postdocs at MUSC prepare to launch their research careers thanks to "pathway to independence" grant awards.

How a team of MUSC researchers is trying to take meditation practices into the future by merging cutting-edge brain stimulation with mindfulness.

$5.3 million National Cancer Institute (NCI) grant allows Hollings Cancer Center to be able to enroll more cancer patients into clinical trials.

Local surf therapy program for veterans hopes to share its treatment protocol with veterans everywhere.

Kids with asthma who had access to school-based telehealth were 21% less likely to visit the emergency department.

MUSC rolls out new cost-saving methods for the university’s power that are not only good for Mother Earth but the bottom line as well.

Study on brain structure changes can affect performance in space.

Veterans suffering from PTSD may get a new option that virtually takes doctor with them during treatment.

MUSC researchers report in Science Advances that the protein, P17/PERMIT, could prove to be a connection between neurodegeneration and cancer.

MUSC team tapped to develop the prototype of a cloud-based tool to measure impact of clinical and translational research nationwide.

To battle the opioid epidemic, researchers need real-time data to design trials and enough participants for those trials. MUSC team is enhancing a tool to help.

Leaders expect that adding MUSC's regional hospitals to the mix of rotation spots for MUSC students will help grow the state's health care workforce.

MUSC Hollings Cancer Center researcher Dr. Jessica Thaxton was on winning team at renowned immunotherapy event.

MUSC researchers report in Nature Communications they have obtained 3D structural snapshots of Cdc34 in action.

Individuals, teams inspire innovative ideas and solutions.

What is IQOS, how does it work – and how does it compare to vaping and traditional cigarettes?

Pet therapy offers stress relief to patients and staff alike. Now you can give back.

The National Crime Victims Research and Treatment Center and Division of General Pediatrics collaborated to provide integrated care to kids exposed to trauma.

Breast cancer patient fights cancer while pregnant, raises awareness for research and prevention.

Scaling up locally successful wellness initiatives benefits kids across the state.

MUSC researchers identify mutations in ciliary genes causing bicuspid aortic valve – the most common heart valve birth defect.

Infections due to illegal opioid use often land people in the hospital. Researchers say this could be a chance to help people with long-term treatment.

A new grant will allow MUSC researchers to test ideas for improving care and outreach to people with lupus or at risk of developing the autoimmune disease.

Chronic alcohol use can alter brain circuitry, sending users into a pattern of relapse drinking. The ARC tests drugs that could help people break that pattern.

To find the organisms that would lead to one of the most rewarding inventions he’s ever been involved with, microbiologist Hal May had to get down and dirty.

By studying lipoproteins in pregnant women with type 1 diabetes, MUSC researchers aim to understand and potentially predict preeclampsia.

Dr. Patrick Woster is one of only four researchers worldwide to be inducted this year into the Medicinal Chemistry Hall of Fame.

The Community-Engaged Scholars Program fosters academic/community partnerships to ensure that health care research is meaningful for the region's residents.

One death and dozens of hospitalizations have been linked to vaping. But wait, isn't vaping better than smoking?

As public health officials worry about antibiotic-resistant gonorrhea starting to appear, an MUSC researcher is tracking down the source of the resistance.

Heart doctor and nurses celebrate a beloved patient’s 100th birthday. She reached this milestone thanks to being part of a clinical trial.

Clemson head coach Dabo Swinney did a public service announcement for LOWVELO, an outdoor bike ride to fund breakthrough cancer research.

MUSC professor Mulugeta Gebregziabher, Ph.D., left his homeland of Ethiopia when he was 18 to pursue an education in the United States.

Researchers have found that consumption of energy drinks can lead to a spike in blood pressure

This couple’s amazing love story has them riding tandem in LOWVELO. And get this – one of them is just learning to ride a bike.

Cachexia research advances to better target debilitating effects of cancer-related wasting syndrome.

The Blue Dogs will headline the opening ceremony Nov. 1 at LOWVELO, an outdoor bike ride that raises money for cancer research at MUSC Hollings Cancer Center.

Hollings Cancer Center clinical scholar researches novel triple-negative breast cancer treatments.

More and more, research points to diet as a factor in Alzheimer's disease. An MUSC researcher considers how restricting certain foods could avert the disease.

MUSC study shows black women with a history of pregnancy problems need to know that they’re at higher risk of heart problems later in life.

When Satish Nadig heard about President Donald Trump’s executive order on kidney health, he was stunned. In a great way.

Family with history of kidney disease donates $1.5 million to MUSC Transplant Research and Immunobiology Institute.

Dr. Raymond DuBois and colleagues link high-fat diet to molecular changes that can cause colorectal cancer to spread.

When she began her leadership, Tricia Bentz inherited a new program that recognized physicians for their time and effort participating in clinical research.

Researchers at MUSC Hollings Cancer Center publish their findings on how a natural antioxidant help improve immune-based therapies by modulating T-cells.

The NCI awards a $3M grant to the Hollings Cancer Center researchers to continue work on an immunotherapy combination to treat lung cancer.

MUSC investigators find that many African American children have a variation of a gene linked to lower vitamin D status.

Hollings Cancer Center researchers probed deeper into how cell division cycles are regulated.

Burnout is a public health crisis, says an MUSC expert. It’s finally getting the serious scrutiny it deserves.

Older men with scleroderma have more estrogen than postmenopausal women with the disease. This could explain why the disease is often more severe in men.

A potential breakthrough treatment for opioid addiction will be tested at MUSC.

Race plays a role in how vitamin D affects the vaginal microbiome.

There was blood in the water at MUSC’s Shark Tank event, but luckily, there were plenty of doctors on hand.

MUSC investigators report in Science Translational Medicine that defects in the primary cilia of the developing fetus cause mitral valve prolapse.

Patricia Chase is a pretty independent person, but she takes Lucy and Fred with her wherever she goes.

T-VEC, also known as talimogene laherparepvec, is a type of oncolytic virus therapy.

MUSC researchers exploit a metabolic Achilles heel in esophageal cancer to identify potential new therapy.

MUSC researchers use natural language processing, a type of artificial intelligence, to identify socially isolated patients.

Hollings Cancer Center joins local and state leaders to celebrate the renewal of its designation as a National Cancer Institute (NCI) Cancer Center.

When 'time is brain,' rural doctors must quickly decide if a stroke patient should be transferred. MUSC docs are working on guidelines to help those decisions.

Diving into the details: A lipid-binding pocket is a target for new cancer therapies

Dr. Kathleen Brady wins Governor's Award for Excellence in Science.

A new state-of-the-art mass spectrometer promises to improve the detection and characterization of proteins for investigators at MUSC.

Hollings Cancer Center announces five fellowship awardees.

MUSC study finds that peppermint oil improves symptoms of non-cardiac chest pain and difficulty swallowing in patients with certain disorders of the esophagus.

Classrooms weren't the only things devastated by Hurricane Maria. An MUSC-led survey shows traumatic impact on some of Puerto Rico's young people.

There's a toxic cycle happening deep in the cells of some veterans of the first Gulf War. An MUSC researcher thinks he's on the trail of halting that cycle.

Recent MUSC grad Jasper Heinsbroek wins award to jump-start research into brain circuits behind addiction.

Heart abnormalities are at once the most common and most deadly type of birth defect in the U.S.

“There really weren’t any red flags.” A mother’s story makes the importance of neurodevelopmental research hit home at an MUSC conference.

A study released today in JAMA Network Open reported that smoking after a cancer diagnosis is associated with substantial additional costs of cancer treatment.

Researchers find evidence of a link between "leaky gut" and autoantibody production in HIV-positive patients.

The Medical Technology Enterprise Consortium (MTEC) held its national conference in Charleston March 20 and 21 and invited MUSC researchers to attend.

An MUSC team makes an important finding about heart disease in lupus.

Researchers are just getting started figuring out what's happening in the brain. Hesheng Liu is in the forefront of resting state fMRI research.

The story of GARP: A potential target for cancer immunotherapy.

Hollings researcher receives funding to harness power of imaging

MUSC researchers identify a brain circuit responsible for cocaine-seeking behavior during relapse

Abstinence shouldn't be the only goal in helping people with drinking problems, a new paper argues.

Dean Raymond DuBois to receive Margaret Foti Award for Leadership and Extraordinary Achievements in Cancer Research.

Kids have a blast with MUSC researchers who show the fun side of science at the Charleston STEM festival.

'Breakthrough' nasal spray studied at MUSC to treat severe depression wins FDA approval.

When Glenda Davis-Allen was diagnosed with lupus, she felt terribly alone. She doesn't want that to happen to the next generation.

Hollings Cancer Center recently announced four funding awards, two as part of its Fellowship Program and two as part of its Clinical Scholar Program.

Adding the 'cuddle hormone' to a behavioral counseling program could improve the odds for couples struggling with alcohol use, researcher believes.

A gut microbe of interest has been identified for the autoimmune disease lupus, report researchers at the Medical University of South Carolina and elsewhere.

An MUSC team is sharing its expertise in trauma-focused cognitive behavioral therapy with therapists in El Salvador who work with children.

One member of a protein family known to be complicit in fibrotic diseases such as systemic sclerosis turns out instead to protect against it.

Researchers reveal a novel binding site for a class of anti-cancer drugs using X-ray crystallography.

Something is off with the math of Alzheimer’s disease. African-American seniors are twice as likely to have it as white seniors.

MUSC's Data Coordination Unit has helped answer a long-debated question about how to deal with high blood sugar in stroke patients.

When Ted McRackan realized the usual way of measuring cochlear implant outcomes didn't match patients' real-world experience, he set out to find a better way.

Hollings Cancer researchers have discovered cell membrane complexes called ceramidosomes that may be a new target for drugs to kill cancer cells.

Nobel prize winner Elizabeth Blackburn speaks to a packed house at MUSC about how telomeres affect human health.

Research identifies one possible explanation for why male and females react differently to methamphetamine in an animal model study.

A new federal award creates a partnership to bring innovative biotechnology ideas from the university to the marketplace.

Is a chemical in everything from cocoa to laxatives linked to metabolic and weight-related problems?

Gender matters when it comes to quitting smoking.

Brain researchers sound alarm as humans prepare for extended time in space.

Study peers into teens' brains as they grow into adulthood.

Researchers at the Medical University of South Carolina have identified a potential therapeutic target for lung fibrosis.

MUSC, Clemson researchers re-imagine operating room in an effort to improve quality, safety and outcomes.

Plan to buy four community hospitals fits with MUSC's strategic plan, leaders say, and new facilities will be financially self-sustaining.

Hollings Cancer Center researchers explore how to enhance adoptive cell transfer.

Researchers found sepsis outcomes in preclinical model improved when a microRNA was delivered by nanocarrier.

Hollings Cancer Centers researchers probe interventions that can help smokers quit.

Findings provide a target for a new addiction treatment being tested at MUSC.

HCC researchers uncover clues to better outcomes and pinpoint health disparity issues

Hollings Cancer Center researchers say a new compound enhances a treatment for multiple myeloma in preclinical models.

Smartphone app improves teamwork and communication in trauma care and earns national honor.

A clinical trial using DFMO to prevent relapse in children with High Risk Neuroblastoma gets good results..

Chanita Hughes-Halbert receives AACR Distinguished Lecture on the Science of Cancer Health Disparities.

Fish Charleston Harbor, Cooper River and Ashley River tested for pollutants.

A team of Hollings Cancer Center gets $1.2 million grant to test antibody that could block breast cancer growth with fewer side effects.

Cyclist George Hincapie is coming to Hollings Cancer Center on Nov. 11 to lead the Jerry Zucker Ride for Hope.

Doctors hoped device would prevent sudden death in heart attack patients.

In studying breast cancer, researchers keep open minds that lead to surprising find.

Study on value of second opinion for breast cancer patients found review by a tumor board changed diagnosis for 43 percent of patients.

LGBTQ community needs assessment, a survey that is attempting to assess the state of the LGBTQ community in Charleston, Berkeley and Dorchester counties.

Researchers are just beginning to understand how the microbiome can influence the health of its host.

Leukogene Therapeutics receives funding to develop compound for resistant multiple myeloma.

Scientists at Hollings Cancer Center found that some cells can divide without a molecule that was previously thought necessary.

Research details functional breakdowns that lead to cancer, point to therapeutic possibilities.

Dr. Kevin M. Gray will talk pros and cons of pot at Aug. 22 Science Cafe.

Lupus expert explains beneficial effect of cells with potential life-changing implications.

MUSC resident Ezequiel “Zeke” Gleichgerrcht explores new way to figure out which epilepsy patients need surgery.

Partnership between Dr. Satish Nadig and Dr. Carl Atkinson brings infusion of vitality to organ transplant program.

A TV program co-produced by MUSC Public Information and Community Outreach and SC ETV has won a Bronze Telly Award.

Researcher Betty Tsao is on the trail of lupus, tracking down the cause of the autoimmune disease.

Scientists at Hollings Cancer Center have found a link between cancer and aging inside our cells.

MUSC Health patients are part of a national study using a virus to try to beat back recurrent glioblastomas.

International trial leads to big change in treatment for some women with breast cancer.

New guidelines from the American College of Cardiology/American Heart Association lower threshold for high blood pressure.

While the tumor-killing effects of chemotherapy are critical in treatment, at times there are damaging effects to healthy tissues, including bone marrow.

High-density mapping technology for heart patients may mean safer, more effective treatments.

MUSC faculty member says ingredient in drug known as Ecstasy and Molly appears to have helped veterans and first responders cope with PTSD.

MUSC is running multiple studies designed to fight chronic liver disease.

Lung cancer researchers at Hollings Cancer Center test accuracy of blood test that measures the levels of two proteins.

MUSC researcher will talk about how yoga is being scientifically studied as possible adjunct treatment for everything from pain to PTSD.

HCC expert provides insight to addressing cancer health disparities at annual conference.

Results from a clinical trial to treat lung cancer show an immunotherapy combination is surprisingly effective at controlling the disease’s progression.

Woman travels from Virginia to MUSC for a trial testing whether cells created with material from donor hearts can help people suffering from heart failure.

Matthew Carpenter is both fascinated and concerned. The tobacco and nicotine researcher is holding a Juul.

Weight Management Center's Patrick O'Neil returns from conference where he highlighted news-making results.

Hollings Cancer Center awarded seven cancer scientists funding as part of its Fellowship Program.

Colorectal cancer is on the rise in younger adults. A survivor shares her story.

Multi-site study will use non-invasive brain stimulation to try to get stroke-disabled hands moving.

Carsten Krieg, Ph.D., and other cancer researchers hope to advance the field of immunotherapy.

Denis C. Guttridge to serve as director of Darby Children’s Research Institute, associate director of translational sciences for Hollings Cancer Center

Public health scientist Amy Martin will give the next Science Cafe talk for the Medical University of South Carolina.

Judith Green continues the legacy of her husband, finds joy in advocating for cancer causes.

Three Medical University of South Carolina brain researchers have more than $7M in grants from NIH to study Alzheimer's.

MUSC and Clemson collaborate to create a safer, more efficient operating room.

Statisticians at MUSC found advances in brain imaging can identify a greater number of stroke patients who can receive therapy later than previously believed.

Technique pioneered at MUSC may help some stroke patients.

An MUSC study found a mechanical initial specimen diversion device and staff education led to a decrease in contaminated blood cultures.

A clinical trial will study whether dietary and exercise interventions can decrease advanced glycation end products that have been linked to cancer

Recent study shows e-cigarettes may help reduce smoking and increase quit attempts

Researcher Andy Shih and his lab take advantage of properties of light to visualize what happens in brain during stroke.

When neurosurgeon Bruce Frankel encounters a problem, his mind goes into high gear.

An innovative study looking at hair loss in a preclinical model reveals clues to how cancer spreads in a recent issue of Science Signaling.

Breakthrough discovery finds that T cells with a protein called CD26 on their surface have the best cancer-fighting potential.

Dr. Stuart Parnham relishes his role at MUSC working with nuclear magnetic resonance spectroscopers.

BEACH Program targets environmental impacts on human health

$3.8M grant funds research testing whether stem cells can help people with treatment-resistant lupus.

Researchers create powerful cancer fighters in the lab that could one day be used to treat patients.

NASA study funds neuroradiologist, team in groundbreaking science studying the brain.

Study looks at why women run greater risk for depression during medical internship year

Cancer surgeon and researcher Nancy DeMore leads trial using frankincense to try to treat breast and colon cancer.

Fast-track research focused on developing a new gene-modifying sickle cell disease treatment could lead to human clinical trials in as few as three years.

Study untangles addiction and relapse in the brain.

Study lets kids help kids while learning about science.

Researchers receive $20 million, 5-year grant from National Science Foundation’s Established Program to Stimulate Competitive Research.

Could phthalates, chemicals found in everything from vinyl flooring to soft plastics, affect babies before they're even born?

Researchers at the Medical University of South Carolina have identified a little-known molecule as a suspect behind liver disease.

MUSC is spearheading several efforts to stem the tide of opioid addiction, including the SC MAT ACCESS project.

Data specialists at the Medical University of South Carolina help patients across country get better care in emergency departments.

Astronaut's speech and the idea of conducting research in space captivate MUSC scientists

Research may help explain how certain breast and lung cancers grow and spread

MUSC researchers are looking into what happens in the brain when people lose the ability to communicate and how to use this information to help recovery.

A concussion detection aid developed at MUSC may one day help with field sobriety testing or detect diseases such as Parkinson’s, Huntington’s and schizophrenia

In lab tests, several of Latrunculia austini’s molecules selectively target and kill pancreatic and ovarian tumor cells.

The FDA could OK the use of the “living drug” approach for kids and young adults with B-cell acute lymphoblastic leukemia who haven't responded to treatment

Originally from Montevideo, Uruguay, Mariana Pehar has been fascinated by the brain since she was young. That fascination could someday lead to a cure for ALS.

Chris Cull isn’t your typical keynote speaker. Not that long ago, the filmmaker and public speaker was hooked on opioids and stealing food to survive.

In patients with colitis, inflammatory T cells in the lower intestines mistake food or healthy gut bacteria for dangerous pathogens that must be destroyed.

Dean G. Kilpatrick, Ph.D., and Michael G. Schmidt, Ph.D., were awarded the state’s highest honor, the Governor’s Award for Excellence in Science

An ambitious long-term study of brain development and child health seeks to find out more about what sets an individual's trajectory.

A young patient's replicated tumor cells provide access to the juvenile pilocytic astrocytoma cell line to researchers around the world.

The potential applications of resident memory T cells for adoptive immunotherapy are not limited to melanoma.

Vigorous walking three to five times each week decreases the chance of recurrent stroke by fivefold in patients with narrowed arteries in the brain

While performing a lumpectomy, Nancy DeMore asked herself why there wasn’t an easier way to do the procedure that wouldn’t involve two invasive procedures.

Reducing the appeal and addictiveness of tobacco products would go a long way towards speeding up an end to the tobacco problem

For those with narcolepsy, a neurological disorder that impairs the body’s ability to regulate sleep, sleep can be dangerous and life-altering.

The Project Quit team is dedicated to understanding the innermost mechanics of nicotine addiction and working with smokers who are struggling with it.

A new office will provide support to MUSC researchers.

Cardiac glycosides, found in the leaves of the foxglove plant, could reduce LDL cholesterol differently than statins, potentially providing a new treatment.

The Women’s Scholars Initiative presented MIT's Dr. Nancy Hopkins with the 2017 Eminent Scholar Award at Hollings Cancer Center

A nationwide genetic study aims to track down clues to the causes of autism with the goal of potentially developing new treatments. MUSC is the SC site.

Two of the 18 pathogens of concern in the United States may have a direct link to agriculture — one of them being salmonella.

A new gene therapy offers hope for people living with sickle cell disease.

Raymond DuBois is well known as dean of the College of Medicine at MUSC, but not everyone knows the strong advocacy work he does in the fight against cancer.

A virus that exclusively affects rabbits could also kill a certain type of blood cancer cells in humans.

Individual differences in brain biology could be the reason some people have a harder time quitting smoking.

A state policy change increased the number of toddlers with ASD receiving early intervention services. The new policy could serve as a model for other states.

Could crowdsourcing family health history help predict who might get cancer?

Researchers have found promising therapeutic targets for personalized medical approaches to treating heavy drinking.

The MUSC chapter of the National Academy of Inventors inducted 12 new members and honored Dr. Craig Beeson, who was named a national fellow in 2016.

Four children and three grandchildren of Lee Patterson Allen inherited her kidney disease. The family has donated to MUSC to fund a research lab in her name.

New research shows that mini-strokes pack a more powerful punch in people suffering from dementia than previously believed.

Hollings Cancer Center joins other NCI center to support new HPV vaccine recommendations from CDC.

The protein GARP could be targeted by an antibody to treat breast, colon and lung cancers.

Researcher's top tips to keep teens from alcohol abuse

Improving the treatment of head and neck cancers by enhancing immune response

297 abstracts were submitted for MUSC's 51st annual Research Day.

Could parents and health care providers intervene earlier if they need which risk factors at age 12 would lead to alcohol abuse later in life?

Many of our daily activities are driven by routine. But what happens when those routines are harmful?

Antioxidant may help veterans suffering from PTSD and substance use disorders

Gotcha Bike, MUSC set to roll with Charleston's first bike share

Over-the-counter antioxidant may help teens cut back on drinking

Pediatric telehealth gets ready to 'Sprout'

Researcher makes inroads in spinal cord injury research

Saluting campus veterans for their military service

Charleston massage therapist finds renewed sense of purpose a long way from home

Mothers literally give part of themselves to save sons

Study suggests home-based telemental health delivers better quality of life for veterans

Neuroscientist studies connection between PTSD and alcohol abuse

Scientific retreat tackles tough issues of health disparities, racism

Physician releases second suspense novel

Athlete who almost died returns to thank team that helped save him, and gets thanked right back

Pharmacist explores new methods to reduce medication errors

Patients eager to test device that might ease heart failure symptoms

Man who made a living with language adapts to life after aphasia

Testing stem cells as possible treatment for heart failure

Summer internship program leads undergrads to research track

MUSC-led study tries to increase HIV testing and treatment

Study puts Weight Watchers to the test for Type 2 diabetes

MUSC hosts movie screening, discussion about bipolar disorder

Expanded access to nutrition experts helps families across the state lose weight

Finding the clues for better autism treatments

MUSC employees step up to relocate babies before the storm

Transplant surgeon urges donors to get in the game at TEDxCharleston event

Boy's eyes tell scary story about his liver

Infants, moms benefit from MUSC's Milk Preparation Room

Researchers probing the beneficial secrets in dolphins' proteins

ECHO Program explores how environment affects kids' health

Reaching lives through Project Hope

Healing kids' burn wounds through family-friendly technology

MUSC leads state in biomedical research funding

MUSC part of innovative national cancer trial

Noted liver cancer researcher joins Hollings Cancer Center

Researcher's 'magic bullet' for spinal cord injuries: Estrogen

Graduate Studies awarded career training grant

Olympic dreams: Mom, family support gold medal jumper in Rio

Game-changing procedures show spine center expertise

Spinal cord injury researcher inspires at faculty convocation

Researchers harness power of viruses to fight cancer

Group advances Hispanics, Native Americans in science

Harper's first birthday marks celebration, chance to support research

MUSC registers annual economic impact of $3.8 billion in Charleston metro area

No judgment, lots of support in group treatment for mood disorders

Researchers report important findings about African-American patients' hearts

Groundbreaking for new children's hospital captures special moments

Mom of twins brings personal perspective to hospital planning